Skip to main content
. 2021 Dec 16;6(4):e979. doi: 10.1097/PR9.0000000000000979

Table 1.

Patient anthropometrics, median of opioid consumption, and pain origin, in accordance to the diagnosis.

Variable Methadone (n = 175) Morphine (n = 87) Total (n = 262)
Gender* n (%)
 Female 116 (66.3%) 49 (55.7%) 165 (62.7%)
 Male 59 (33.7%) 38 (44.3%) 98 (37.3%)
Age 62.1 (±15.5) 55.5 (±12.02) 59.2 (±14.9)
Opioid consumption 12.6 (±13.3) 47.4 (±57.6)
Cancer-related pain§ 17 (9.7%) 42 (48.2%) 59 (22.5%)
Pain origin
 Nociceptive 53 (30.2%) 51 (56.0%) 104 (39.7%)
 Neuropathic# 41 (23.4%) 16 (18.3%) 57 (21.7%)
 Mixed** 61 (34.8%) 17 (19%) 78 (29.8%)
 Nociplastic†† 19 (10.8%) 2 (2.2%) 21 (8%.0%)
 Missing data‡‡ 1 (0.8%) 1 (4.5%) 2 (0%.8%)
*

P = 0.106 (Fisher test).

Mean (standard deviation), P = 0.0002 (t test).

Mean during the entire follow-up period (standard deviation), value expressed in mg.

§

P < 0.0001 (Fisher test).

Mean; mixed pain = neuropathic and nociceptive components, P values (Fisher test).

P = <0.0001.

#

P = 0.42.

**

P = 0.014.

††

P = 0.015.

‡‡

P = 1.